Manifold MarketsGeen KYCGeverifieerde afwikkelingsgegevensRedelijk gekalibreerdHuidige gemeenschapsvoorspellingNee 81.9%
Voorspellers
7
Vraagtype
binary
Methodologie
Play-money forecasting platform
Brontype
Voorspelling
Marktdata
Bijgewerkt 1 uur geleden
Vertraagd14 jan 25, 02:36 UTC2 jan 32, 07:59 UTC
Trends
Regels
Openwater (https://openwater.health) has a device that damages cancer cells selectively with ultrasound.
- This market will resolve YES if any cancer treatment using Openwater's ultrasound technology is approved by the FDA before January 1, 2032 for one or more cancer indications.
- Any FDA approval for treating cancer outside of a clinical trial counts, even if it only covers a small set of patients.
- If Openwater's technology gets transferred to another entity, use of that technology will count as long as it involves focused ultrasound.
- I have a blog post about the treatment here: https://bayesianinvestor.com/blog/index.php/2025/01/13/openwaters-cancer-treatment/
